XML 37 R26.htm IDEA: XBRL DOCUMENT
v3.25.4

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) | 3 Months Ended
--- | ---
Jan. 31, 2026
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES |
Schedule of fair value of derivative instruments | As of January 31, 2026, and October 31, 2025, all derivative instruments were recorded at fair value on our Condensed Consolidated Balance Sheets as follows (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | January 31, 2026 | ​ | October 31, 2025
​ | ​ | Balance Sheet | ​ | Fair | ​ | Balance Sheet | ​ | Fair
Derivatives | ​ ​ ​ | Location | ​ ​ ​ | Value | ​ ​ ​ | Location | ​ ​ ​ | Value
Designated as Hedging Instruments: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Foreign exchange forward contracts | ​ | Derivative assets | ​ | $ | 19 | ​ | Derivative assets | ​ | $ | 215
Foreign exchange forward contracts | ​ | Derivative liabilities | ​ | $ | 1,288 | ​ | Derivative liabilities | ​ | $ | 945
​ | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ |  | ​
Not Designated as Hedging Instruments: | ​ | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​
Foreign exchange forward contracts | ​ | Derivative assets | ​ | $ | 63 | ​ | Derivative assets | ​ | $ | 48
Foreign exchange forward contracts | ​ | Derivative liabilities | ​ | $ | 1,846 | ​ | Derivative liabilities | ​ | $ | 2,139
Schedule of effect of derivative instruments on the balance sheets, statements of changes in shareholders' equity and statements of operations | Derivative instruments had the following effects on our Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Changes in Shareholders’ Equity, and Condensed Consolidated Statements of Operations, net of tax, during the three months ended January 31, 2026 and 2025 (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Location of Gain | ​ | Amount of Gain
​ | ​ | Amount of Gain (Loss) | ​ | (Loss) Reclassified | ​ | (Loss) Reclassified
​ | ​ | Recognized in Other | ​ | from Other | ​ | from Other
​ | ​ | Comprehensive | ​ | Comprehensive | ​ | Comprehensive
Derivatives | ​ | Income (Loss) | ​ | Income (Loss) | ​ | Income (Loss)
​ | ​ | Three Months Ended | ​ | ​ | ​ | Three Months Ended
​ | ​ | January 31, | ​ | ​ | ​ | January 31,
​ | ​ ​ ​ | 2026 | ​ ​ ​ | 2025 | ​ ​ ​ | ​ | ​ ​ ​ | 2026 | ​ ​ ​ | 2025
Designated as Hedging Instruments: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
(Effective portion) |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |  | ​ | ​
Foreign exchange forward contracts – Intercompany sales/purchases | ​ | $ | (731) | ​ | $ | (96) | ​ | Cost of sales and service | ​ | $ | (142) |  | $ | (522)
Foreign exchange forward contract – Net investment | ​ | $ | (69) | ​ | $ | 106 | ​ | ​ | ​ |  | ​ | ​ |  | ​
Schedule of derivative instruments not designated as hedging instruments | We recognized the following gains and losses in our Condensed Consolidated Statements of Operations during the three months ended January 31, 2026 and 2025, on derivative instruments not designated as hedging instruments (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Location of Gain | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | (Loss) Recognized | ​ | Amount of Gain (Loss)
Derivatives | ​ ​ ​ | in Operations | ​ | Recognized in Operations
​ | ​ | ​ | ​ | Three Months Ended
​ | ​ | ​ | ​ | January 31,
​ | ​ | ​ | ​ ​ ​ | 2026 | ​ ​ ​ | 2025
Not Designated as Hedging Instruments: |  | ​ |  | ​ | ​ |  | ​ | ​
Foreign exchange forward contracts |  | Other income (expense), net | ​ | $ | (1,551) |  | $ | (1,093)
Schedule of changes in the components of accumulated other comprehensive loss, net of tax | The following table presents the changes in the components of Accumulated other comprehensive loss, net of tax, for the three months ended January 31, 2026 (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Foreign Currency | ​ | Cash Flow | ​ | ​ | ​
​ | ​ ​ ​ | Translation | ​ | Hedges | ​ ​ ​ | Total
Balance, October 31, 2025 | ​ | $ | (8,234) | ​ | $ | (774) | ​ | $ | (9,008)
Other comprehensive income (loss) before reclassifications | ​ |  | 178 | ​ | ​ | (731) | ​ |  | (553)
Reclassifications | ​ |  | — | ​ | ​ | 142 | ​ |  | 142
Deferred income tax valuation allowances | ​ |  | — | ​ | ​ | (197) | ​ |  | (197)
Balance, January 31, 2026 | ​ | $ | (8,056) | ​ | $ | (1,560) | ​ | $ | (9,616)

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accumulated other comprehensive income (loss). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 + Details
Name: | us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4CC -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CC Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 182 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480401/815-10-55-182 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4B -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4CC -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4B -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B + Details
Name: | us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration